Distal 22q11.2 microduplication syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:261337Q92.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Distal 22q11.2 microduplication syndrome (Orphanet code 261337) is a rare chromosomal anomaly caused by a duplication of a segment in the distal (far) portion of the long arm of chromosome 22, within the 22q11.2 region but distinct from the more commonly known proximal 22q11.2 duplication. This condition results in an extra copy of genetic material that can affect multiple body systems, leading to a variable clinical presentation. The distal 22q11.2 region is nested between low-copy repeats (LCRs) and is separate from the region typically involved in DiGeorge/velocardiofacial syndrome duplications. Clinical features are highly variable, even among affected members of the same family. Commonly reported findings include developmental delay, intellectual disability (often mild to moderate), speech and language delays, and behavioral difficulties. Growth retardation, including prenatal and postnatal growth restriction, has been described. Some individuals may present with mild dysmorphic facial features, skeletal anomalies, and congenital heart defects, though the cardiac involvement tends to be less prominent than in proximal 22q11.2 duplications. Neurological features such as hypotonia and seizures have also been reported in some cases. There is no specific cure or targeted therapy for distal 22q11.2 microduplication syndrome. Management is supportive and symptom-based, involving early intervention programs, speech therapy, occupational therapy, physical therapy, and special educational support. Cardiac anomalies, if present, are managed according to standard cardiological protocols. Genetic counseling is recommended for affected individuals and their families, as the duplication may be inherited from a mildly affected or apparently unaffected parent, or may arise de novo. The phenotypic variability and incomplete penetrance make prognosis difficult to predict on an individual basis.

Also known as:

Clinical phenotype terms— hover any for plain English:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Distal 22q11.2 microduplication syndrome.

View clinical trials →

No actively recruiting trials found for Distal 22q11.2 microduplication syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Distal 22q11.2 microduplication syndrome community →

No specialists are currently listed for Distal 22q11.2 microduplication syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Distal 22q11.2 microduplication syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Distal 22q11.2 microduplication syndromeForum →

No community posts yet. Be the first to share your experience with Distal 22q11.2 microduplication syndrome.

Start the conversation →

Latest news about Distal 22q11.2 microduplication syndrome

No recent news articles for Distal 22q11.2 microduplication syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Distal 22q11.2 microduplication syndrome

What is Distal 22q11.2 microduplication syndrome?

Distal 22q11.2 microduplication syndrome (Orphanet code 261337) is a rare chromosomal anomaly caused by a duplication of a segment in the distal (far) portion of the long arm of chromosome 22, within the 22q11.2 region but distinct from the more commonly known proximal 22q11.2 duplication. This condition results in an extra copy of genetic material that can affect multiple body systems, leading to a variable clinical presentation. The distal 22q11.2 region is nested between low-copy repeats (LCRs) and is separate from the region typically involved in DiGeorge/velocardiofacial syndrome duplicat

How is Distal 22q11.2 microduplication syndrome inherited?

Distal 22q11.2 microduplication syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.